JPRN-jRCT2080222167未知2 期
A randomized, double-blind, 4-way crossover, placebo-controlled, phase II study to evaluate the efficacy and safety of TAC-202/bilastine in Japanese cedar pollinosis exposure to antigen in an environmental exposure chamber (EEC).
适应症
试验速览
- 阶段
- 2 期
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 60age old（—）
- 性别
- All
入选标准
- •Subjects have a history of seasonal allergic rhinitis at the past 2 pollen seasons and had received medication (including oral anti-histaminic drug).
- •Subjects between 20 and 60 years of age at the time of signing the informed consent.
- •Subjects are available to complete all study measurements.
排除标准
- •Subjects with nose, ocular or ear complications which are disturbed the assessment of efficacy for the study drug.
- •Subjects with a history of intranasal operative treatment (coagulation necrosis or excision).
- •Subjects with a history of specific immunotherapy (including sublingual) or nonspecific immunotherapy within 5 years prior to consent acquisition.
- •Subjects who had treatment with steroid within 30 days prior to consent acquisition.
研究者
相似试验
进行中（未招募）
1 期
In this study, Bravo capsules are being used to measure oesophageal pH in order to assess reflux suppression by Gaviscon Double Action MintThis study assesses suppression of gastro-oesophageal reflux of Gaviscon in patients with gastro-oesophageal reflux disease.EUCTR2012-004109-28-GBReckitt Benckiser Healthcare (UK) Ltd28
进行中（未招募）
不适用
A randomized, four-way cross-over, double-blind, controlled study of oral donepezil (2, 5, 10 mg) in patients with moderate to severe obstructive sleep apnea.EUCTR2005-003789-40-SEPharmapnea AB30
进行中（未招募）
不适用
A randomised, double-blind, four way cross-over, placebo controlled trial to evaluate the clinical efficacy, onset of action and drug activity at 22-26 hours following the drug intake of Bilastne 20 mg vs placebo and in competition to Cetirizine 10 mg, Fexofenadine 120 mg in reducing symptoms of seasonal allergic rhinitis in grass pollen sensitized volunteers exposed on 2 consecutive days in the Vienna Challenge ChamberEUCTR2006-003004-19-ATFAES Farma S.A.76
已完成
不适用
A randomized, double blind, two-way crossover clinical trial to evaluate of pharmacokinetic profiles of lacosamide in Korean subjectsKCT0003959Dong-A University Hospital48
已完成
不适用
A double-blind, randomised, double dummy, cross over, study to assess the difference in efficacy between nebulisation of rhDNase before airway clearance therapy (ACT) versus nebulisation after ACTCystic Fibrosis (CF)Nutritional, Metabolic, EndocrineCystic FibrosisISRCTN87248226Roche Nederland BV (Netherlands)25